Is There a Rationale for the Use of an Alpha-Melanocyte-Stimulating Hormone Analog to Improve Gray Hair Repigmentation?

    November 2022 in “ Skin Appendage Disorders
    Daniel Fernandes Melo, Sandra Tagliolatto, Ana Cecília Studart, Bruna Fanton Gallo, Carla Jorge Machado, Simone Carolina Frattini, Flávia Weffort, Rita Fernanda Cortez de Almeida
    TLDR PT-20 did not significantly improve gray hair repigmentation.
    This study investigated the use of palmitoyl tetrapeptide 20 (PT-20), an α-melanocyte-stimulating hormone analog, for gray hair repigmentation in 14 patients over 6 months. Despite theoretical benefits, the results showed no significant clinical improvement in hair repigmentation, with 78.6% of patients showing no change according to at least two examiners. The study highlights the discrepancy between patient self-assessment and examiner evaluations, possibly due to patient expectations. The authors note the study's limitations, including a small sample size and short duration, and call for further research to validate these findings.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 504 results

    Similar Research

    5 / 1000+ results